A Study of Safety, Pharmacokinetics (Including Food Effect) And Pharmacodynamics of RO5545965 in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

53

Participants

Timeline

Start Date

October 31, 2012

Primary Completion Date

March 31, 2013

Study Completion Date

March 31, 2013

Conditions
Healthy Volunteer
Interventions
DRUG

Placebo

Single ascending dose

DRUG

RO5545965

Single ascending dose

DRUG

RO5545965

Single dose, in fed and fasted state

Trial Locations (1)

9471 GP

Zuidlaren

All Listed Sponsors
lead

Hoffmann-La Roche

INDUSTRY

NCT01711801 - A Study of Safety, Pharmacokinetics (Including Food Effect) And Pharmacodynamics of RO5545965 in Healthy Volunteers | Biotech Hunter | Biotech Hunter